EVICORE SMARTCHOICE LAB
DEAD

Serial Number

90321319

Owner

CareCore National LLC

Attorney

Alexandra MacKay

Filing Date

Nov 16, 2020

Add to watchlist:

No watchlists yet
View on USPTO

EVICORE SMARTCHOICE LAB Trademark

Serial Number: 90321319

EVICORE SMARTCHOICE LAB is a trademark filed by CareCore National LLC on November 16, 2020. The trademark is classified under Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

CareCore National LLC (24 trademarks)

400 Buckwalter Place Blvd
Bluffton, SC 29910

Entity Type: 16

EVICORE HEALTHCARE MSI, LLC (31 trademarks)

400 BUCKWALTER PLACE BLVD.
BLUFFTON, SC 29910

Entity Type: 16

Trademark Details

Filing Date

November 16, 2020

Registration Date

Not Registered

Published for Opposition

October 17, 2023

Goods & Services

Electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments and referrals that allow direct transaction, authorization and payment communications between healthcare providers, patients and payers; providing access to databases in the fields of medical diagnosis guidance and evidence-based healthcare

Medical benefit management services; medical benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits; claims administration services in the field of health insurance; medical insurance case and utilization review and insurance claims adjustment services for healthcare purchasers, payers, providers, and beneficiaries of health plans; administration of managed health care plans

Medical cost management; managed care services, namely, utilization review and pre-certification and post-certification services in the fields of inpatient admission management, molecular genomic lab services, comprehensive lab services, and diagnostic lab services, specialty drug medical benefit; cost management for the health care benefit plans of others; managed care services, namely, electronic processing of health care information; organization and coordination of health care services, namely, appointment coordination services and arranging managed care contractual services in the fields of diagnostic imaging, advanced imaging, nuclear medicine, radiation therapy, medical oncology medical benefit, medical oncology pharmacy benefit, cardiac and nuclear cardiac imaging, echo stress testing, diagnostic heart catheterization, ultrasound services, sleep management testing and treatment, sleep diagnostics, pap therapy devices and supplies, therapy support services, cardiac device care, post-acute care management, durable medical equipment, home infusion, bundled payments, musculoskeletal care, spine surgery, joint surgery, interventional pain, implant management, inpatient admission management, molecular genomic lab services, comprehensive lab services, and diagnostic lab services, gastroenterology, upper endoscopy, colonoscopy, lower endoscopy, capsule endoscopy, specialty drug medical benefit, occupational therapy, physical therapy, speech therapy, chiropractic care, acupuncture, massage therapy, and opioid management; evidenced-based health care cost management services and healthcare utilization and review services; managed care services, namely, electronic processing of health care information via the internet; health care cost management services for healthcare benefit plans of others and risk-bearing provider organizations being medical cost management services

Software as a service (SAAS) services featuring software for use in connection with evidence-based healthcare and insurance, namely, the development and implementation of algorithms and analytical models from evidence-based medical criteria for purposes of a medical utilization review and reporting, and verifying the requesting provider's adherence to evidence-based medicine guidelines and determining the appropriate intensity of medical utilization review based upon the requesting provider's prior history; application service provider (ASP), featuring software for use in developing, analyzing, and maintaining information and database management in the fields of healthcare, benefits programs, employee productivity, and risk management; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of healthcare benefit plans for others; molecular and genetic lab services; software as a service (SAAS) services featuring software for optimizing healthcare utilization, managing utilization and financial risk for healthcare payers, assisting physicians in making clinical decision, and analyzing data to help health care providers track clinical decisions and develop best practices; software as a service (saas) services featuring software for use in automating tasks and storing data in the field of healthcare; providing online internet based non-downloadable computer software to perform prior authorizations services for healthcare providers and payers; providing online non-downloadable software for use by healthcare providers to search and retrieve clinical and non-clinical data from electronic medical records; computer services, namely, providing a cloud-enabled service in the nature of providing temporary use of non-downloadable cloud-based software for others that automates the prior authorization process for medical benefits

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 1, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 1, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 1, 2024 EX1G
SOU EXTENSION 1 FILED
Jun 1, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 1, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 12, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 12, 2023 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 22, 2023 RCCK
ASSIGNED TO EXAMINER
May 16, 2023 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 19, 2023 ASGN
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 2, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 6, 2022 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 4, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 4, 2021 GNSL
SUSPENSION LETTER WRITTEN
Nov 4, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 28, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2021 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 27, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 27, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 27, 2021 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 29, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 29, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 29, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2021 NWOS
NEW APPLICATION ENTERED
Nov 19, 2020 NWAP